Onconetix (ONCO) vs Silexion Therapeutics (SLXN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Onconetix is the larger company by market cap ($3.2 million vs $3.1 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ONCO | SLXN |
|---|---|---|
| Share price | $0.62 | $0.2146 |
| Market cap | $3.25M | $3.11M |
| 1-day change | -5.24% | -8.64% |
| P/E ratio (TTM) | 0.00 | — |
| EPS (TTM) | $310.39 | $-27.21 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $207.00 | $40.70 |
| 52-week low | $0.58 | $0.2079 |
| Distance from 52-week high | -99.70% | -99.47% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +2229.92% |
| Average volume | 2.96M | 9.90M |
| Shares outstanding | 5.24M | 14.47M |
| Employees | 2 | 13 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Onconetix
ONCO stock →Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology in the United States, the European Union, and Non-European Union. The company offers Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer.
Health Care · Biotechnology: Pharmaceutical Preparations · 2 employees
About Silexion Therapeutics
SLXN stock →Silexion Therapeutics Corp, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of solid tumors through its proprietary LODER delivery platform.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 13 employees
ONCO vs SLXN FAQ
Which is bigger, Onconetix or Silexion Therapeutics?
Onconetix (ONCO) is larger, with a market capitalization of $3.25M compared with $3.11M for Silexion Therapeutics (SLXN).
Are Onconetix and Silexion Therapeutics in the same industry?
Both are in the Health Care sector, but in different industries: Biotechnology: Pharmaceutical Preparations for Onconetix and Biotechnology: Biological Products (No Diagnostic Substances) for Silexion Therapeutics.